Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > It takes money to advance oncology R&D

<< Previous

Bullboard Posts

Next >>

Comment by CAinPlapon Mar 08, 2023 11:59am

116 Views

Post# 35326028

RE:RE:RE:RE:RE:RE:It takes money to advance oncology R&D

Yes despite being corrected several times on BTD designation application, he continues to say that TLT said we would have it in Dec 2022 rather than the factual would be in a position to apply for it. My only beef may be if they are waiting to apply until reaching 34 - 37 patients, that we could have been updated. Perhaps this will be part of the next update.

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1